跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 84 条关于
“HSDD”
全部
84
临床试验
49
药物
26
机构
0
资讯
9
4个月前
Acrux Advances Female Testosterone Therapy to Phase III for HSDD Treatment
去年
FDA Grants Priority Review for Flibanserin Expansion to Postmenopausal Women with HSDD
9个月前
FDA Approves Expanded Flibanserin Indication for Postmenopausal Women with Hypoactive Sexual Desire Disorder
去年
FDA Approves Addyi: First Pill to Combat Low Libido in Women
2个月前
Arletta Pharma Secures FDA Endorsement for Lybrido Phase 2 Program, Eyes Streamlined Path to NDA for Female Sexual Interest/Arousal Disorder
18天前
Study Finds Women With Hypoactive Sexual Desire Disorder Still Engage in 'Mercy Sex' Two to Three Times Monthly
14年前
GIP Reduces Free Fatty Acids via 11β-HSD1 Inhibition in Adipose Tissue
上个月
Tufts CSDD Benchmarking Study, Commissioned by Syneos Health, Links Clinical Sourcing Models to Trial Performance and Quality
上个月
Tufts CSDD Analysis Finds AI Clinical Monitoring Agents Can Deliver Up to $21 Million in Net Financial Value Per Drug Program